Santuril®

(500 mg probenecid containing tablets)

Probenecid, (4-(dipropylsulfamoyl) benzoic acid inhibits the organic anion-transport across cell membranes by binding to to the relevant membrane transporter polypeptides thereby increasing urinary uric acid excretion while decreasing renal excretion and increasing plasma levels of drugs (ATC-Code: M04AB01).

Santuril® (500 mg Probenecid containing tablets) is an uricosuric agent.

Santuril (probenezid)

Santuril® (500 mg Probenecid containing Tablets) is registered and available in packs of 30 and 100 tablets each in the following countries: